why choose us

First received: July 26, 2022

Clinical Trial: DECIDE-CV Using AI

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes

Study Type: OBSERVATIONAL


Official Title: Delivering Evidence Based Care Using Artificial Intelligence to Patients With Diabetes and CardioVascular Comorbidities: The DECIDE-CV Innovation Project

Brief Summary: The purpose of this study is to identify digital biomarkers associated with type 2 diabetes mellitus (T2DM) by combining sensor data from a wrist-worn wearable and clinical data.This will be done by recruiting patients with and without diabetes within the cardio-metabolic clinics a the MUHC.Consented patients will be provided with a HOP Technologies (HOP) watch in this project across two observation periods.The Watch-HOP platform facilitates the development of predictive algorithms built with data collected in a…

Read more